• Synergy Pharmaceuticals inks deal with Luxion Pharma biospectrumasia
    August 13, 2018
    The deal gives Luoxin exclusive rights to develop and commercialize Synergy’s lead product TRULANCE (plecanatide) for the treatment of adults with chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C) in mainland Chi
PharmaSources Customer Service